NumFin

Genetic Technologies Limited

Symbol: GTG.AX

ASX

0.125

AUD

Market price today

  • -0.8258

    P/E Ratio

  • -0.1243

    PEG Ratio

  • 16.53M

    MRK Cap

  • 0.00%

    DIV Yield

Genetic Technologies Limited (GTG-AX) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Genetic Technologies Limited (GTG.AX). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Genetic Technologies Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

balance-sheet.row.cash-and-short-term-investments

07.911.720.9
14.2
2.2
5.5
11
11.2
18.3
2.8
1.9
8.9
5.1
3.4
9.7
12.9
12.5
11.1
17.7
11.3
5.8
7.2
0.6
1.2

balance-sheet.row.short-term-investments

0000
0
0.1
0
0
0
0
0
0.2
0
0
0.1
0
0.5
0
0
0
0
0.3
0
0
0

balance-sheet.row.net-receivables

00.22.41.1
0
0
0
0.2
0.4
0.5
0.9
0.3
0.5
0.7
0.8
2.3
1.6
0.6
1.4
1.2
1.6
1.2
0.2
0.2
0.1

balance-sheet.row.inventory

00.30.40.1
0.1
0
0.1
0.1
0.2
0.3
0.2
0.2
0.3
0.5
0.3
0.6
0.9
0.5
0.6
0
0
0.3
0.8
2.5
4.1

balance-sheet.row.other-current-assets

02.100
0.8
1
0.4
0.4
0.4
0.4
0.4
0.2
0.2
0
0.1
0
0.5
0
0
0.8
0
0
0.1
0.1
0

balance-sheet.row.total-current-assets

010.514.722.2
15.2
3.2
6
11.6
12.1
19.6
4.4
2.7
9.9
6.3
4.5
12.5
15.9
13.7
13.1
19.7
13
7.4
8.2
3.4
5.4

balance-sheet.row.property-plant-equipment-net

00.610.6
0.4
0.1
0.2
0.5
0.6
0.4
0.4
0.4
0.6
0.9
2
3.7
1.7
1.9
2.3
2.6
1.8
1.5
0.5
0.8
0.3

balance-sheet.row.goodwill

03.14.54.5
0
0
0
0
0
0
0.3
0.3
0.3
0.3
0.3
1.6
0.3
0.3
0.3
0.5
0
0.5
0
0
0

balance-sheet.row.intangible-assets

00.50.65.1
0
0
0
0
0.6
0.7
0.9
1
1.1
1.4
1.5
5.7
6
3.3
5.1
6.2
6.9
20.2
24
27.4
0

balance-sheet.row.goodwill-and-intangible-assets

03.65.19.6
0
0
0
0
0.6
0.7
1.2
1.3
1.4
1.7
1.8
5.7
6.3
3.7
5.5
6.2
6.9
20.6
24
27.4
0

balance-sheet.row.long-term-investments

04.100
0
0
0
0
0
0
0.8
3.9
4.4
0
0
0.3
0.2
0
0
0
0
0.7
0
0
0

balance-sheet.row.tax-assets

00.100
0
0
2.5
0
0
0
0.8
0
0
0
0
1.1
-0.2
0
0
0
0
-0.7
0
0
0

balance-sheet.row.other-non-current-assets

0-4.2-6.1-9.5
-0.4
-0.1
-2.5
-0.5
-1.2
-1.2
-1.6
-5.7
0
0
0
-1.1
0
1.7
1.6
0.7
0.7
0
0.3
8.1
3.1

balance-sheet.row.total-non-current-assets

04.26.10.7
0.4
0.1
0.2
0.5
1.2
1.2
1.6
5.7
6.5
2.7
3.8
9.8
8.2
7.3
9.3
9.6
9.4
22.9
24.8
36.3
3.4

balance-sheet.row.other-assets

00.100
0
0
0
0
0
0
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

014.920.823
15.6
3.3
6.2
12.1
13.3
20.7
6.7
8.3
16.4
8.9
8.3
22.3
24.1
21
22.4
29.3
22.4
30.2
33
39.7
8.8

balance-sheet.row.account-payables

00.81.20.3
0.4
0.6
0.5
0.4
0.4
0.5
0.9
0.6
0.9
1.1
1.2
2.7
1.8
1.6
1.4
3
2
1.4
0
0
0

balance-sheet.row.short-term-debt

00.30.30.2
0.2
0
0
0
0
0
-0.2
0
0
0.1
0.4
0.5
0.1
0.5
0.5
0.4
0
0
0
0.1
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0.5
0.3
0
0
0
0
0.4
0
0
0

balance-sheet.row.long-term-debt-total

00.20.40
0.1
0
0
0
0
0
2.5
0
0
0
0
0
0.2
0.7
1.2
0.7
0.7
0.7
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01.31.61
1
0.9
0.9
1.1
0.9
1.1
1.4
1.5
0.7
0.7
0.7
1.3
1
0.9
1
1
2
1.6
1.9
1.5
1.3

balance-sheet.row.total-non-current-liabilities

00.40.60
0.1
0
2.5
0.1
0.1
0
2.5
0.1
0.1
0.1
0.1
0.1
0.3
0.8
1.2
1.6
0.7
0.7
0
0
0

balance-sheet.row.other-liabilities

0000
0.2
0
-2.5
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
-0.7
0
0
0

balance-sheet.row.capital-lease-obligations

00.20.70.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

03.74.41.4
1.6
1.5
1.5
1.5
1.4
1.8
4.9
2.6
2
2.1
2.6
4.8
3.3
4.1
4.2
6.5
5.3
3
1.9
1.6
1.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0161.3155.1153.6
140.1
125.5
122.4
122.4
115.3
115.2
90.1
83.7
83.3
72.4
72.4
88.3
70.2
0
38
36.2
24.7
39.7
39.4
54
20.2

balance-sheet.row.retained-earnings

0-156.7-150.2-143.1
-136
-129.7
-123.3
-117.8
-109.4
-101
-92.2
-82
-72.8
-67.5
-66.8
-71
-51.3
-21.7
-22.9
-17
-10.4
-12.3
-8.2
-17.9
-14.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

06.511.511
8.8
6
5.7
6
6.1
4.7
3.9
4
3.7
-5.6
-1.4
-5.6
1.6
4.8
3
3.5
2.6
1.4
0
0
0

balance-sheet.row.other-total-stockholders-equity

0000
1.2
0
0
0
0
0
0
0
0
7.3
1.4
5.6
0.2
33.7
0
0
0
-1.5
0
2
1.9

balance-sheet.row.total-stockholders-equity

011.216.421.5
14
1.8
4.7
10.6
11.9
19
1.8
5.6
14.2
6.6
5.5
17.3
20.7
16.8
18.1
22.6
17
27.3
31.1
38.1
7.6

balance-sheet.row.total-liabilities-and-stockholders-equity

014.920.823
15.6
3.3
8.7
12.1
13.3
20.7
6.7
8.3
16.4
8.9
8.3
22.3
24.1
21
22.4
29.3
22.4
30.2
33
39.7
8.8

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0
0
0

balance-sheet.row.total-equity

011.216.421.5
14
1.8
4.7
10.6
11.9
19
1.8
5.8
14.4
6.8
5.7
17.5
20.8
16.9
18.3
22.8
17.1
27.4
31.1
38.1
7.6

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0.1
0
0
0
0
0
4.1
4.4
0
0.1
0.3
0.7
0
0
0
0
1
0
0
0

balance-sheet.row.total-debt

00.50.70.2
0.5
0
0
0
0
0
2.5
0
0
0.1
0.4
0.5
0.3
1.2
1.7
0.7
0.7
0.7
0
0.1
0

balance-sheet.row.net-debt

0-7.3-11.1-20.7
-13.7
-2.1
-5.5
-11
-11.2
-18.3
-0.3
-1.7
-8.9
-5
-2.9
-9.2
-12.6
-11.2
-9.4
-17
-10.6
-5.1
-7.2
-0.5
-1.2

Cash Flow Statement

The financial landscape of Genetic Technologies Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

cash-flows.row.net-income

0-11.8-7.1-7.1
-6.3
-6.4
-5.5
-8.4
-8.5
-8.8
-10.1
-9.3
-5.3
0.9
-9.4
-9.7
-5.5
-1.7
-5.4
-7.5
-6.9
-4.3
-8.8
-3.4
-2.4

cash-flows.row.depreciation-and-amortization

00.70.60.5
0.3
0.2
0.3
0.4
0.4
0.2
0.3
0.4
0.6
0.6
3.7
4.9
4.8
1.7
2.4
1.5
0.6
3.5
4.1
3.5
0.3

cash-flows.row.deferred-income-tax

0-0.61.8-0.4
0.1
0.2
-0.3
-0.3
-0.1
-0.5
0.7
0.3
-7.2
-1.7
-0.2
-2
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00.30.40.7
0
0.3
0.1
0.1
0.1
0.3
0.1
0.2
2
0.3
0
-0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

00.3-2.2-0.3
0
-0.5
0.1
0.2
0.1
0.2
-0.8
0.7
0.1
-0.1
-0.2
0.9
-1.1
0.9
-3.3
-0.4
1.3
0
0
0
0

cash-flows.row.account-receivables

00.3-1.9-0.3
0
-0.5
0.1
0.2
0.1
0.2
-0.8
0.2
0.2
0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00.1-0.40
-0.1
0
0
-0.2
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-0.42.20
0.7
0.1
0
0.1
-0.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00.4-2.20
-0.7
-0.1
0
-0.1
0.3
0
0
0.5
-0.1
-0.2
-0.2
0.9
-1.1
0.9
-3.3
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

01.40.90.3
0.3
0.2
-0.5
0.9
0.2
-1.6
-0.5
0.2
2.1
2.2
1.8
-0.1
2.2
1.2
0.2
-0.1
0.4
-0.2
1.4
-2.3
1.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-0.1-0.6
0
-0.1
0
-0.2
-0.3
-0.2
0
-0.1
-0.1
-0.1
-0.4
-0.3
-0.1
-0.2
-0.2
-0.6
-0.9
-0.2
-0.2
-0.1
0

cash-flows.row.acquisitions-net

0-0.5-3.50
0
0
0
0.1
0
2.1
-0.2
0
0
0
-1
0
0
0
0
0
0
0
0.3
-0.2
-0.9

cash-flows.row.purchases-of-investments

0000
-0.1
-0.5
0
0
0
0
-0.1
0
0
0
0.2
-0.6
0
0
0
0
0
0
-0.1
-2.4
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0.6
0
0
0
0.3
0
0
0
0
0
0
0
9.2
-0.1
0

cash-flows.row.other-investing-activites

00.20.10
0.1
0
0
0
0
0.1
0
-0.2
0.6
0.1
-0.2
0.4
0.1
0.3
0
0.6
0
0.5
0.1
4.4
1.8

cash-flows.row.net-cash-used-for-investing-activites

0-0.3-3.5-0.6
0.1
-0.5
0
-0.1
-0.3
2
0.2
-0.2
0.5
0
-1
-0.4
0
0.2
-0.2
0
-0.9
0.3
9.3
1.6
0.9

cash-flows.row.debt-repayment

0-0.3-0.3-0.2
-0.2
0
0
0
0
0
0
0
-1.1
-0.3
-0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

06.3015.9
18.6
3.1
0
6.8
0
23.3
7
0.5
10.9
0
1
0
0
0
0
13.5
10.3
0
0.6
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-0.90-1.7
0
-0.4
0
0.3
0
-0.4
4.9
0
1
0
0
-0.2
-0.5
-0.5
-0.5
-0.3
-0.3
0
-0.1
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

05.9-0.313.9
18.4
3.1
0
7.1
0
22.9
11.9
0.4
10.9
-0.3
0.8
-0.2
-0.5
-0.5
-0.5
13.2
10
0
0.5
0
0

cash-flows.row.effect-of-forex-changes-on-cash

00.20.3-0.1
-0.6
0.1
0.1
-0.3
0.9
0.4
-0.1
0.1
0.1
-0.1
0
-0.1
-0.3
1.2
-0.3
0.7
1.1
-0.6
0
0.1
0

cash-flows.row.net-change-in-cash

0-3.921.46.7
12.1
-3.4
-5.5
-0.2
-7.2
15.5
1.1
-7.2
3.8
1.8
-4.5
-6.9
-0.4
3.1
-7
7.3
5.7
-1.3
6.5
-0.6
0.6

cash-flows.row.cash-at-end-of-period

07.911.720.9
14.2
2.1
5.5
11
11.2
18.3
2.8
1.7
8.9
5.1
3.3
9.7
13.4
12.5
11.1
17.7
11.3
5.8
7.2
0.6
1.2

cash-flows.row.cash-at-beginning-of-period

011.7-9.614.2
2.1
5.5
11
11.2
18.3
2.8
1.7
8.9
5.1
3.3
7.8
16.6
13.8
9.3
18.1
10.4
5.6
7.2
0.6
1.2
0.7

cash-flows.row.operating-cash-flow

0-9.7-5.7-6.3
-5.7
-6.1
-5.6
-6.8
-7.7
-9.7
-11
-7.5
-7.7
2.2
-4.3
-6.1
0.4
2.2
-6.1
-6.6
-4.5
-1
-3.3
-2.2
-0.3

cash-flows.row.capital-expenditure

00-0.1-0.6
0
-0.1
0
-0.2
-0.3
-0.2
0
-0.1
-0.1
-0.1
-0.4
-0.3
-0.1
-0.2
-0.2
-0.6
-0.9
-0.2
-0.2
-0.1
0

cash-flows.row.free-cash-flow

0-9.7-5.8-6.9
-5.8
-6.1
-5.6
-7
-8
-9.9
-11
-7.6
-7.8
2.1
-4.7
-6.4
0.3
2
-6.3
-7.2
-5.4
-1.2
-3.5
-2.4
-0.3

Income Statement Row

Genetic Technologies Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of GTG.AX is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

income-statement-row.row.total-revenue

010.36.80.1
0.8
0
0.2
0.5
0.8
2
4.6
3.4
11.3
18.3
9.8
6.7
15.7
13.8
9.9
9.5
3.8
9.3
13.1
5.6
4

income-statement-row.row.cost-of-revenue

04.30.30.4
0.1
0.3
0.3
0.5
0.7
1.3
2.9
1.9
1.9
2
2.7
2.7
0.9
6.6
8.1
4.6
3.2
0
0
0
0

income-statement-row.row.gross-profit

066.5-0.2
0.7
-0.3
-0.1
0
0.1
0.7
1.6
1.4
9.4
16.2
7
3.9
14.8
7.2
1.8
4.9
0.6
9.3
13.1
5.6
4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00-1.50.1
-0.8
0.1
0
0
0.1
0.6
-0.6
0
0
0
4.6
5.1
4.9
4.2
4.2
10.2
5.9
12
20.7
8.8
6.8

income-statement-row.row.operating-expenses

018.13.17
7
6.2
5.3
8.4
8.6
9.3
11.2
10.6
15.3
15.2
14.7
20.2
16.8
8.7
8
12.6
8.3
13.6
22
9.1
6.8

income-statement-row.row.cost-and-expenses

022.43.47.4
7.1
6.5
5.6
8.9
9.3
10.6
14.1
12.5
17.2
17.2
2.7
22.9
17.7
15.3
16.1
17.2
11.4
13.6
22
9.1
6.8

income-statement-row.row.interest-income

00.200.1
0
0
0
0
0
0.2
0.6
0.2
0.6
0.2
0.2
0
0
0.5
0.8
0.6
0.5
0
0
0
0

income-statement-row.row.interest-expense

0000
0
0
0
0
0
0.3
0.7
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.5-4.30.1
-0.4
0.6
0.9
-0.2
0
1.1
0.1
-0.4
0
-0.1
-16.3
-1.8
-3.5
-0.3
0.1
-0.1
0.6
-1
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00-1.50.1
-0.8
0.1
0
0
0.1
0.6
-0.6
0
0
0
4.6
5.1
4.9
4.2
4.2
10.2
5.9
12
20.7
8.8
6.8

income-statement-row.row.total-operating-expenses

0-1.5-4.30.1
-0.4
0.6
0.9
-0.2
0
1.1
0.1
-0.4
0
-0.1
-16.3
-1.8
-3.5
-0.3
0.1
-0.1
0.6
-1
0
0
0

income-statement-row.row.interest-expense

0000
0
0
0
0
0
0.3
0.7
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

00.40.60.3
0.1
0.2
0.3
0.4
0.4
0.2
0.3
0.4
0.6
0.6
3.7
4.9
4.8
1.7
2.4
1.5
0.6
3.5
4.1
3.5
0.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-10.4-7.5-7.4
-5.9
-7
-6.4
-8.2
-8.5
-9.9
-10.2
-9.1
-5.9
1
-7.7
-8.2
-1.9
-1.6
-6.2
-7.8
-7.7
-4.3
-8.9
-3.4
-2.8

income-statement-row.row.income-before-tax

0-11.9-7.2-7.1
-6.3
-6.4
-5.5
-8.4
-8.5
-8.8
-10.1
-9.3
-5.3
0.9
-9.4
-9.7
-5.5
-1.4
-5.3
-7.2
-6.8
-4.3
-8.9
-3.4
-2.8

income-statement-row.row.income-tax-expense

00.20-0.1
-0.8
-0.9
-0.3
-0.3
-0.4
0
0
-0.8
0
-0.5
-3.6
0.1
3.5
0.2
0.1
0.3
0
0.2
-0.1
-0.1
-0.4

income-statement-row.row.net-income

0-11.8-7.1-7.1
-6.3
-6.4
-5.5
-8.4
-8.5
-8.8
-10.1
-9.3
-5.3
0.9
-9.3
-9.7
-5.5
-1.7
-5.4
-7.5
-6.9
-4.3
-8.8
-3.4
-2.4
Similar Stocks
You may also be interested in:
8225.HK
China Health Group Inc..
0.119 HKD
HKSE
RVTY
Revvity, Inc..
104.34 USD
NYSE
LAB
Standard BioTools Inc..
2.41 USD
NASDAQ
IDXX
IDEXX Laboratories, Inc..
500.82 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.305 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.655 AUD
ASX
DGX
Quest Diagnostics Incorporated.
138.16 USD
NYSE
QIA.DE
Qiagen N.V..
40.345 EUR
XETRA
300685.SZ
Amoy Diagnostics Co., Ltd..
20.57 CNY
SHZ
603259.SS
WuXi AppTec Co., Ltd..
44.6 CNY
SHH

Frequently Asked Question

What is Genetic Technologies Limited (GTG.AX) total assets?

Genetic Technologies Limited (GTG.AX) total assets is 14856237.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is -0.376.

What is company free cash flow?

The free cash flow is -0.059.

What is enterprise net profit margin?

The net profit margin is -1.437.

What is firm total revenue?

The total revenue is -1.197.

What is Genetic Technologies Limited (GTG.AX) net profit (net income)?

The net profit (net income) is -11750923.000.

What is firm total debt?

The total debt is 532846.000.

What is operating expences number?

The operating expences are 18112539.000.

What is company cash figure?

Enretprise cash is 0.000.